Successful twin pregnancy in a patient with ulcerative colitis using azathoprine during conception.
Inflammatory bowel disease (IBD) frequently affects young patients of childbearing age. Treatments for inflammatory bowel disease include immunosuppressive, cytotoxic and surgical therapies. Azathioprine is frequently used to treat patients with steroid dependent IBD. We report the case of a patient with ulcerative colitis, treated with azathioprine prior to conception and during the subsequent pregnancy with the subsequent successful delivery of healthy twins. Although some potential risks indeed exist, the use of AZA may not be harmful to the mother or the fetus in many instances.
Division of Internal Medicine, Desio General Hospital, Italy.
Giovanni
G
Casella
2 Pathology Section, Spedali Civili, Brescia, Italy.
Vincenzo
V
Villanacci
Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, Italy.
Elisabetta
E
Antonelli
Pathology Unit, Desio General Hospital, Italy.
Camillo
C
Di Bella
Division of Internal Medicine, Desio General Hospital, Italy.
Vittorio
V
Baldini
Research Center of Gastroenterology and Liver disease, Shahid Beheshti University of Medical sciences, Tehran, Iran.
Mohammad
M
Rostami Nejad
Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, Italy.
Gabrio
G
Bassotti
Azathioprine; Conception; Twin pregnancy; Ulcerative colitis